Assessing the onset of the drug-drug interaction between Paxlovid and tacrolimus
Drug interactions between Paxlovid and Tacrolimus in kidney transplant patients diagnosed with COVID-19
Sponsor: Pfizer
Enrolling: Male and Female Patients
IRB Number: AAAV2718
Contact: Transplant Clinical Research Center: 212-305-3839 / tcrcstudyreferral@cumc.columbia.edu
Additional Study Information: This purpose of this study is to understand the interaction between two different medications, tacrolimus and Paxlovid (nirmatrelvir/ritonavir), in patients who have had a kidney transplant and are being treated by their doctor for COVID-19 infection. Tacrolimus is an oral medication that is used standardly in kidney transplant recipients to prevent rejection of the transplanted kidney. Paxlovid is an oral medication that is used to treat COVID-19 infection. Both medications are being prescribed by the patient's provider as part of their routine care. Participants will be asked to use a device called the TASSO M20 to collect blood at home at several timepoints around the doses of Paxlovid and tacrolimus. This is a small device that allows for collection of a tiny amount of blood at home by pricking the skin of your upper arm. If you have any questions regarding this study, please contact the Transplant Clinical Research Center (TCRC).
Investigator
Marcus Pereira, MD, MPH
Do You Qualify?
Have you had a kidney transplant? Yes No
Have you been diagnosed with COVID-19? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder


CAPTCHA
Image CAPTCHA
Enter the characters shown in the image.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Cancel
For more information, please contact:
Transplant Clinical Research Center
tcrcstudyreferral@cumc.columbia.edu
212-305-3839
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE